undamentalytics Newsletter

Immuneering Corp valuation and forecast

Explore the models for Immuneering Corp, adjust their assumptions and compare your own valuation with the platform's.

Stock price today

Loading chart…

Third-party market data · may be delayed

Fair value per share

Under review: data-quality checks not passed.

Price vs value

Under review: data-quality checks not passed. We'll show the comparison once resolved.

Analyst recommendations

7 analysts, Oct 2026
Buy7100%
Hold00%
Sell00%

Monthly trend

  1. Oct 2026257
  2. Sep 2026257
  3. Aug 2026257
  4. Jul 2026257

Counts of recommendations published by analysts covering Immuneering Corp, by month. Source: Aggregated broker recommendations (third-party data). Aggregated counts only: we do not reproduce any firm's recommendation or price target, and these are not Fundamentalytics ratings.

Price history

Loading chart…

Third-party market data · may be delayed

IMRX valuation questions

How does Fundamentalytics value Immuneering Corp?
We use the models that fit Immuneering Corp's business and available financial data: forward price-to-sales vs peers. Each model has its own assumptions and data requirements. The calculator explains which models are available and lets you adjust their inputs.

Data: SEC EDGAR filings, retrieved November 1, 2026. Method: how we value companies. Disclosures: research and recommendations disclosure. Back to Immuneering Corp.